Are Phase 3 Clinical Trials Really Becoming More Complex?

Conclusions:
In general, there is limited evidence for significant increases in the study and protocol design and execution of phase 3 clinical trials sponsored by pharmaceutical companies.

Source: Therapeutic Innovation and Regulatory Science - October 21, 2015 Category: Drugs & Pharmacology Authors: Glass, H. E., DiFrancesco, J. J., Glass, L. M., Tran, P. Tags: Product Development and Innovation Source Type: research